Luping Lin
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
-
- Lung Cancer Treatments and Mutations
Papers in
-
- Cancer Genomics and Diagnostics 2
- Cancer, Hypoxia, and Metabolism 2
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Trever Grant Bivona (6 shared papers)David Paul Carbone (3 shared papers)Victor R. Olivas (4 shared papers)Elton Chan (3 shared papers)Saurabh Asthana (3 shared papers)Dana S. Neel (2 shared papers)Sourav Bandyopadhyay (2 shared papers)Jenny Jiacheng Yan (2 shared papers)
- Journals
- ACS Medicinal Chemistry Letters (3 papers)Nature Genetics (2 papers)Cancer Research (2 papers)Cell Reports (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Luping Lin
29 papers receiving 2.6k citations
Luping Lin's Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 972
- Pulmonary and Respiratory Medicine 846
- Cancer Research 388
- Cell Biology 397
- Immunology 407
Countries citing papers authored by Luping Lin
This map shows the geographic impact of Luping Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luping Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luping Lin more than expected).
Fields of papers citing papers by Luping Lin
This network shows the impact of papers produced by Luping Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luping Lin. The network helps show where Luping Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Luping Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer Hit paper breakdown → | 2012 | 1053 |
| 2 | The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies Hit paper breakdown → | 2015 | 462 |
| 3 | 2015 | 240 | |
| 4 | 2015 | 174 | |
| 5 | 2014 | 89 | |
| 6 | 2020 | 82 | |
| 7 | 2012 | 72 | |
| 8 | 2016 | 65 | |
| 9 | 2011 | 64 | |
| 10 | 2010 | 57 | |
| 11 | 2012 | 55 | |
| 12 | 2021 | 54 | |
| 13 | 2016 | 35 | |
| 14 | 2015 | 32 | |
| 15 | 2017 | 28 | |
| 16 | 2019 | 19 | |
| 17 | 2022 | 17 | |
| 18 | 2024 | 17 | |
| 19 | 2023 | 12 | |
| 20 | 2005 | 8 |
About Luping Lin
Luping Lin is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Cell Biology, having authored 32 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Epigenetics and DNA Methylation (4 papers), Melanoma and MAPK Pathways (4 papers), Fibroblast Growth Factor Research (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Protein Tyrosine Phosphatases (2 papers). The work is most often cited by research in Oncology (972 citations), Pulmonary and Respiratory Medicine (846 citations), Cancer Research (388 citations), Cell Biology (397 citations) and Immunology (407 citations). Luping Lin has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Trever Grant Bivona, David Paul Carbone, Victor R. Olivas, Elton Chan, Saurabh Asthana, Dana S. Neel, Sourav Bandyopadhyay, Jenny Jiacheng Yan, Gideon E. Bollag and Evangelos Pazarentzos. Their work appears in journals such as ACS Medicinal Chemistry Letters, Nature Genetics, Cancer Research, Cell Reports and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.